Gracederma Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 7.50 M
as on 23-10-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.60 Cr
as on 23-10-2024
- Revenue 14.79%
(FY 2023)
- Profit 13.89%
(FY 2023)
- Ebitda 22.51%
(FY 2023)
- Net Worth 23.48%
(FY 2023)
- Total Assets 16.42%
(FY 2023)
About Gracederma Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.60 Cr.
Gaurangkumar Shah and Subhashchandra Akbari serve as directors at the Company.
- CIN/LLPIN
U24230GJ2016PTC093672
- Company No.
093672
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gracederma Healthcare Private Limited offer?
Gracederma Healthcare Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Pharmaceutical Medicine, Common Disease Medicines, Pharmaceutical Tablets, Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at Gracederma Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurangkumar Shah  | Director | 09-Sep-2016 | Current |
| Subhashchandra Akbari | Director | 09-Sep-2016 | Current |
Financial Performance of Gracederma Healthcare.
Gracederma Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.79% increase. The company also saw a substantial improvement in profitability, with a 13.89% increase in profit. The company's net worth Soared by an impressive increase of 23.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gracederma Healthcare?
In 2023, Gracederma Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aetherix Lifescience Private LimitedActive 1 year 6 monthsGaurangkumar Shah and Subhashchandra Akbari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Oct 2017 | ₹2.40 Cr | Open |
Others Creation Date: 20 Apr 2017 | ₹1.20 Cr | Open |
How Many Employees Work at Gracederma Healthcare?
Gracederma Healthcare has a workforce of 65 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gracederma Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gracederma Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
